Shire Pharmaceuticals (SHPG) Announces Award Recipients for 2013 US ADHD Scholarship Program
7/19/2013 6:36:29 AM
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
PHILADELPHIA, July 18, 2013 /PRNewswire/ --
Shire, a global specialty biopharmaceutical company, has named the recipients of its 2013 US ADHD Scholarship Program. The program is for individuals in the United States diagnosed with Attention-Deficit/Hyperactivity Disorder (ADHD) who are pursuing higher education at a college, vocational school, or technical school. Fifty award recipients have been selected from  applicants across the United States. The recipients were selected on the basis of an essay explaining how ADHD has impacted their lives, letters of recommendation, community service, and volunteer and extracurricular activities.
Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!
comments powered by